Three Models of Ketamine Treatment for Mental Health

Which Model is Right for You?

https://www.youtube.com/watch?v=sG4Dcd9Tkxo

You might have heard of ketamine referred to as a party drug or an animal tranquilizer, but it is also a legal psychedelic treatment for mental health. With so much information out there and so many ketamine models, which one is the best? Let's break down the three primary models of ketamine mental healthcare to help you or a loved one decide which path makes the most sense.

The Science: How Ketamine Works

First developed in 1962 as a safer alternative to the anesthetic PCP, ketamine received FDA approval for anesthesia in 1970 because it successfully suppressed pain without slowing a patient's heart or lungs. While researchers noticed its antidepressant and psychedelic effects early on, it wasn't until a 2000 study in the year 2000 out of Yale that its psychiatric potential was clearly demonstrated. Researchers found that a smaller, "sub-anesthetic" dose could lift a patient out of a deep depression in just a matter of hours, rather than weeks.

Unlike traditional antidepressants that target dopamine or serotonin, ketamine works on the brain's primary chemical messenger, glutamate. It blocks a specific receptor called NMDA, causing a buildup of glutamate and making the receptors more sensitive to it. It also triggers "synaptogenesis"—the growth of new connections between neurons. This creates a temporary "window of neuroplasticity" where the brain is more adaptable to new feelings and ways of thinking.

Model : The IV Infusion Model

This approach is the most researched and established psychiatric application, often referred to as the "NIMH protocol".

The Process: Patients receive a 40-minute infusion of racemic ketamine directly into the bloodstream while sitting in a monitored medical lounge. A standard induction protocol involves six sessions over the course of two to three weeks.

The Experience: This is a purely pharmacologic intervention with no psychological support included. While doses are kept low and slow to minimize psychedelic effects, patients may still experience them, including potentially difficult trauma memories that can be hard to manage alone.

Cost & Accessibility:Because this is an "off-label" use of the drug, insurance rarely covers it. Out-of-pocket costs range from $400 to $800 per session, making the initial series an investment of $2,400 to $4,800.

Best For: Individuals seeking rapid relief who can afford the out-of-pocket expenses and prefer not to engage in psychotherapy.

Model 2: Spravato (Esketamine)

Approved by the FDA in 2019, Spravato is a nasal spray version of "S-ketamine".

The Process: Patients self-administer the nasal spray in a certified clinic under a safety program called REMS (Risk Evaluation and Mitigation Strategy). After administration, patients must stay for two hours of observation by medical staff.

The Experience: Similar to the IV infusion model, there is no psychological support involved in this approach.

Cost & Accessibility: Because Spravato is FDA-approved, it is routinely covered by insurance, including Medicaid and Medicare. However, to qualify, a patient must be diagnosed with treatment-resistant depression, meaning they have tried and failed one or more first-line treatments. Without insurance, a single dose of Spravato costs nearly $800, compared to around $5 for generic ketamine.

Best For: Those who meet the diagnostic criteria for treatment-resistant depression and need to utilize insurance coverage.

Model 3: Ketamine-Assisted Psychotherapy (KAP)

In the KAP model, the medicine is viewed as a catalyst that opens the door for deep psychological healing, not the entire treatment. This is a form of psychedelic-assisted therapy.

The Process: Treatment begins with screening and preparation sessions to explore your intentions and build trust with a therapist. Dosing sessions last 2.5 to 3 hours, with a therapist present the entire time to help you navigate the experience. This is followed by integration sessions in the following days and weeks to help translate insights into lasting life changes.

The Experience: KAP is defined by its therapeutic support rather than the administration method, which means practitioners might use intramuscular (IM) injections, sublingual lozenges, or infusions.

Cost & Accessibility: Sessions can cost between $400 and $1,000 due to the therapist's time. While insurance might cover some of the therapy hours, it rarely covers the whoel cost of the ketamine sessions.

Best For: This holistic approach is recommended in most situations because it pairs physiological benefits with deep psychological work to address root causes. It is especially effective for those with a history of trauma, where having a safe human presence is vital for healing.

Closing the Gap

While all three models have proven successful, there is currently a significant gap in the science: a lack of large-scale, head-to-head comparative studies. We don't yet have the "gold standard" data to prove whether therapist-supported KAP leads to longer-lasting healing than a clinical IV alone.

Here at Synaptic Institute, we are working to close this gap. We are actively raising funds for a landmark comparative study to help move psychiatry toward a more equitable and supportive future. If you are able, please consider supporting this effort by donating here.